诺泰生物: 诺泰生物：2024年年度权益分派实施公告

Key Points - The company has completed the listing and circulation of all shares from its initial strategic placement [1] - There is no involvement in differentiated dividend distribution or capital increase [1] - The profit distribution and capital increase plan was approved at the annual general meeting on May 23, 2025 [2] - The total share capital before the distribution was 224,870,915 shares, with a cash dividend of 0.80 RMB per share and a capital increase of 0.40 shares per share [2][3] - The total cash dividend distributed amounts to 179,896,732 RMB, and the total shares after the distribution will be 314,819,281 [2][6] - The cash dividend will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch [2] - For individual shareholders, the tax treatment on dividends varies based on the holding period, with different tax rates applied [4][5] - The company will not withhold corporate income tax for institutional investors, who will be responsible for their own tax payments [6]